We are live on ! Find out more
BCAB icon

BioAtla

62 hedge funds and large institutions have $964M invested in BioAtla in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

82% more capital invested

Capital invested by funds: $530M → $964M (+$434M)

41% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 22

17% more funds holding

Funds holding: 5362 (+9)

0.21% more ownership

Funds ownership: 0.97%1.18% (+0.21%)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

Holders
62
Holders Change
+9
Holders Change %
+16.98%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
31
Increased
11
Reduced
12
Closed
22
Calls
Puts
Net Calls
Net Calls Change

BCAB Hedge Fund Activity: Q1 2021 in Review

62 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q1 2021, worth a combined $964M — up 82% from $530M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new BCAB positions and 22 closed out — a net gain of 9 holders — while 11 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $118M. The largest seller was Farallon Capital Management, cutting an estimated $24.4M.

  • 62 institutional investors held BioAtla (BCAB) as of Q1 2021, up from 53 in Q4 2020.
  • Funds reported $964M of BioAtla stock for Q1 2021, up 82% quarter-over-quarter.
  • 31 funds opened new BioAtla positions in Q1 2021 and 22 closed out, a net change of +9 holders.
  • The largest BioAtla buyer in Q1 2021 was Fidelity Investments, an estimated $118M added.
  • The largest BioAtla seller in Q1 2021 was Farallon Capital Management, an estimated $24.4M sold.

Based on aggregated 13F filings for Q1 2021.